Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature review
Author:
Funder
World Health Organization
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference49 articles.
1. Immune checkpoint blockade in cancer therapy;Postow;J Clin Oncol Off J Acad Am Soc Clin Oncol,2015
2. Immune checkpoint inhibitor toxicity in 2018;Johnson;Jama,2018
3. Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors;Hargadon;Int Immunopharm,2018
4. Role of the PD-1 pathway in the immune response;Riella;Am J Transplant Off J Am Soc Trans Am Soc Trans Surg,2012
5. Selective CD28 inhibition modulates alloimmunity and cardiac allograft vasculopathy in anti-CD154-treated monkeys;Zhang;Transplantation,2018
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cetuximab for the treatment of cutaneous squamous-cell carcinoma in kidney transplant recipients – A retrospective cohort study;Journal of Onco-Nephrology;2024-04-22
2. Rapid Life-Saving Response to Anti–PD-1 in a Solid Organ Transplant Recipient With Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review;Journal of Immunotherapy;2024-03-27
3. Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients;Clinical Kidney Journal;2024-03-09
4. Metastatic Melanoma Treatment in Special Populations;The Cancer Journal;2024-03
5. Current practice in liver transplantation;The Liver Graft Before Transplantation;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3